Krystal Biotech Inc Free Cash Flow Generation Index

Latest as of June 2026: 0.95x

Krystal Biotech Inc free cash flow generation index. Krystal Biotech Inc (KRYS) has a Free Cash Flow Generation Index of 0.95x as of June 2026. Free cash flow of $71.22 Million represents 1% of operating cash flow ($74.79 Million).

FCF Generation Index

0.95x
Free Cash Flow / Operating CF

Free Cash Flow

$71.22 Million
USD

Operating Cash Flow

$74.79 Million
USD

Capital Expenditures

$3.56 Million
USD

Free Cash Flow Generation Index of Krystal Biotech Inc (2024–2025)

Free cash flow generation index of Krystal Biotech Inc from 2024 to 2025. Historical FCF Generation Index trend for Krystal Biotech Inc across 2 annual periods. See KRYS financial flexibility score to measure the company's free cash flow as a share of total liabilities.

Krystal Biotech Inc Free Cash Flow Generation Index by Year (2024–2025)

Krystal Biotech Inc free cash flow generation index by year from 2024 to 2025. Year-by-year Free Cash Flow Generation Index for Krystal Biotech Inc. For the full cash flow conversion analysis, see KRYS cash generation efficiency.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2025 0.94x $188.91 Million $200.87 Million $11.95 Million ▼ -2.6%
2024 0.97x $119.18 Million $123.42 Million $4.24 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).